Next Article in Journal
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer
Next Article in Special Issue
Epidemiology, Risk Factors and Diagnosis of Small Bowel Adenocarcinoma
Previous Article in Journal
Translational Regulation by hnRNP H/F Is Essential for the Proliferation and Survival of Glioblastoma
Previous Article in Special Issue
Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and Perspectives
 
 
Review

Article Versions Notes

Cancers 2022, 14(5), 1287; https://doi.org/10.3390/cancers14051287
Action Date Notes Link
article xml file uploaded 2 March 2022 09:50 CET Original file -
article xml uploaded. 2 March 2022 09:50 CET Update https://www.mdpi.com/2072-6694/14/5/1287/xml
article pdf uploaded. 2 March 2022 09:50 CET Version of Record https://www.mdpi.com/2072-6694/14/5/1287/pdf
article html file updated 2 March 2022 09:51 CET Original file -
article html file updated 1 August 2022 03:39 CEST Update https://www.mdpi.com/2072-6694/14/5/1287/html
Back to TopTop